Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-009892

COO and Secretary sold 1,468 shares at an average $74.80 ($109,809)

  • COO and Secretary acquired 4,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schuth Alexander O. COO and Secretary 2021-02-07 Option exercise +4,250 538,812 I
Schuth Alexander O. COO and Secretary 2021-02-09 Sale −1,262 $74.66 $94,218 537,550 I
Schuth Alexander O. COO and Secretary 2021-02-09 Sale −206 $75.68 $15,591 537,344 I
Derivatives
Schuth Alexander O. COO and Secretary 2021-02-07 Option exercise · Restricted Stock Units −4,250 8,500 D
Open-market sales · 1,468 sh · avg $74.80 · $109,809
Loading xslF345X03/doc4.xml…